[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group A (participants aged 18-59 years):Low-dose LYB001: high dose LYB001: placebo=3:3:1;Group B (participants aged over 60 years):Low-dose LYB001: high dose LYB001: placebo=3:3:1;Group C (Participants aged over 18 years):LYB001;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group A (participants aged 18-59 years):Low-dose LYB001: high dose LYB001: placebo=3:3:1", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group B (participants aged over 60 years):Low-dose LYB001: high dose LYB001: placebo=3:3:1", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group C (Participants aged over 18 years):LYB001;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "Low-dose", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "high dose", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]